Antibody-directed myostatin inhibition improves diaphragm pathology in young but not adult dystrophic mdx mice

American Journal of Pathology

Volumn 176, Issue 5, 2010, Pages 2425-2434

  Murphy, Kate T ^a   Ryall, James G ^a,c   Snell, Sarah M ^a   Nair, Lawrence ^a   Koopman, René ^a   Krasney, Philip A ^b   Ibebunjo, Chikwendu ^b   Holden, Kathryn S ^b   Loria, Paula M ^b   Salatto, Christopher T ^b   Lynch, Gordon S ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYOSTATIN;

ADULT; ARTICLE; CONTROLLED STUDY; DIAPHRAGM MUSCLE; DISEASE COURSE; DISEASE SEVERITY; DUCHENNE MUSCULAR DYSTROPHY; FUNCTIONAL STATUS; HUMAN; MOUSE; MUSCLE CELL; MUSCLE FUNCTION; MUSCLE MASS; MUSCULAR DYSTROPHY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

EID: 77952070627     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090932     Document Type: Article

References (39)

1. Emery AE: The muscular dystrophies. Lancet 2002, 359:687-695
2. Lynch GS: Role of contraction-induced injury in the mechanisms of muscle damage in muscular dystrophy. Clin Exp Pharmacol Physiol 2004, 31:557-561 (Pubitemid 39095040)
3. Grounds MD, Davies KE: The allure of stem cell therapy for muscular dystrophy. Neuromuscul Disord 2007, 17:206-208 (Pubitemid 46413761)
4. Radley HG, De Luca A, Lynch GS, Grounds MD: Duchenne muscular dystrophy: focus on pharmaceutical and nutritional interventions. Int J Biochem Cell Biol 2007, 39:469-477 (Pubitemid 46096791)
5. Khurana TS, Davies KE: Pharmacological strategies for muscular dystrophy. Nat Rev Drug Discov 2003, 2:379-390
6. McPherron AC, Lawler AM, Lee SJ: Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member. Nature 1997, 387:83-90
7. Rodgers BD, Garikipati DK: Clinical, agricultural, and evolutionary biology of myostatin: a comparative review. Endocr Rev 2008, 29:513-534
8. Kambadur R, Sharma M, Smith TP, Bass JJ: Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle. Genome Res 1997, 7:910-916 (Pubitemid 27445377)
9. Schuelke M, Wagner KR, Stolz LE, Hubner C, Riebel T, Komen W, Braun T, Tobin JF, Lee SJ: Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 2004, 350:2682-2688
10. Lee SJ: Quadrupling muscle mass in mice by targeting TGF-β signaling pathways. PLoS ONE 2007, 2:e789
11. Lee SJ, McPherron AC: Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci U S A 2001, 98:9306-9311 (Pubitemid 32743912)
12. Welle S, Bhatt K, Pinkert CA, Tawil R, Thornton CA: Muscle growth after postdevelopmental myostatin gene knockout. Am J Physiol 2007, 292:E985-E991
13. Whittemore LA, Song K, Li X, Aghajanian J, Davies M, Girgenrath S, Hill JJ, Jalenak M, Kelley P, Knight A, Maylor R, O'Hara D, Pearson A, Quazi A, Ryerson S, Tan XY, Tomkinson KN, Veldman GM, Widom A, Wright JF, Wudyka S, Zhao L, Wolfman NM: Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. Biochem Biophys Res Commun 2003, 300:965-971
14. Zhu X, Hadhazy M, Wehling M, Tidball JG, McNally EM: Dominant negative myostatin produces hypertrophy without hyperplasia in muscle. FEBS Lett 2000, 474:71-75 (Pubitemid 30320835)
15. LeBrasseur NK, Schelhorn TM, Bernardo BL, Cosgrove PG, Loria PM, Brown TA: Myostatin inhibition enhances the effects of exercise on performance and metabolic outcomes in aged mice. J Gerontol A Biol Sci Med Sci 2009, 64:940-948
16. McCroskery S, Thomas M, Platt L, Hennebry A, Nishimura T, McLeay L, Sharma M, Kambadur R: Improved muscle healing through enhanced regeneration and reduced fibrosis in myostatin-null mice. J Cell Sci 2005, 118:3531-3541
17. Parsons SA, Millay DP, Sargent MA, McNally EM, Molkentin JD: Age-dependent effect of myostatin blockade on disease severity in a murine model of limb-girdle muscular dystrophy. Am J Pathol 2006, 168:1975-1985
18. Wagner KR, McPherron AC, Winik N, Lee SJ: Loss of myostatin attenuates severity of muscular dystrophy in mdx mice. Ann Neurol 2002, 52:832-836 (Pubitemid 35403195)
19. Bogdanovich S, Krag TO, Barton ER, Morris LD, Whittemore LA, Ahima RS, Khurana TS: Functional improvement of dystrophic muscle by myostatin blockade. Nature 2002, 420:418-421 (Pubitemid 35415652)
20. Bogdanovich S, Perkins KJ, Krag TO, Whittemore LA, Khurana TS: Myostatin propeptide-mediated amelioration of dystrophic pathophysiology. FASEB J 2005, 19:543-549 (Pubitemid 40471245)
21. Nakatani M, Takehara Y, Sugino H, Matsumoto M, Hashimoto O, Hasegawa Y, Murakami T, Uezumi A, Takeda S, Noji S, Sunada Y, Tsuchida K: Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice. FASEB J 2008, 22:477-487
22. Shavlakadze T, White J, Hoh JF, Rosenthal N, Grounds MD: Targeted expression of insulin-like growth factor-I reduces early myofiber necrosis in dystrophic mdx mice. Mol Ther 2004, 10:829-843 (Pubitemid 39419910)
23. Grounds MD, Radley HG, Lynch GS, Nagaraju K, De Luca A: Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy. Neurobiol Dis 2008, 31:1-19
24. Stedman HH, Sweeney HL, Shrager JB, Maguire HC, Panettieri RA, Petrof B, Narusawa M, Leferovich JM, Sladky JT, Kelly AM: The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 1991, 352:536-539
25. Lynch GS, Rafael JA, Hinkle RT, Cole NM, Chamberlain JS, Faulkner JA: Contractile properties of diaphragm muscle segments from old mdx and old transgenic mdx mice. Am J Physiol 1997, 272: C2063-C2068
26. Gregorevic P, Plant DR, Leeding KS, Bach LA, Lynch GS: Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration. Am J Pathol 2002, 161:2263-2272 (Pubitemid 35434870)
27. Harcourt LJ, Holmes AG, Gregorevic P, Schertzer JD, Stupka N, Plant DR, Lynch GS: Interleukin-15 administration improves diaphragm muscle pathology and function in dystrophic mdx mice. Am J Pathol 2005, 166:1131-1141 (Pubitemid 40524437)
28. Schertzer JD, Gehrig SM, Ryall JG, Lynch GS: Modulation of insulin-like growth factor (IGF)-I and IGF-binding protein interactions enhances skeletal muscle regeneration and ameliorates the dystrophic pathology in mdx mice. Am J Pathol 2007, 171:1180-1188
29. Dellorusso C, Crawford RW, Chamberlain JS, Brooks SV: Tibialis anterior muscles in mdx mice are highly susceptible to contraction-induced injury. J Muscle Res Cell Motil 2001, 22:467-475 (Pubitemid 34264077)
30. Koopman R, Zorenc AHG, Gransier RJJ, Cameron-Smith D, van Loon LJC: Increase in S6K1 phosphorylation in human skeletal muscle following resistance exercise occurs mainly in type II muscle fibers. Am J Physiol 2006, 290:E1245-E1252
31. Sim J, Reid N: Statistical inference by confidence intervals: issues of interpretation and utilization. Phys Ther 1999, 79:186-195 (Pubitemid 29087002)
32. Cohn RD, Liang HY, Shetty R, Abraham T, Wagner KR: Myostatin does not regulate cardiac hypertrophy or fibrosis. Neuromuscul Disord 2007, 17:290-296 (Pubitemid 46528706)
33. Artaza JN, Reisz-Porszasz S, Dow JS, Kloner RA, Tsao J, Bhasin S, Gonzalez-Cadavid NF: Alterations in myostatin expression are associated with changes in cardiac left ventricular mass but not ejection fraction in the mouse. J Endocrinol 2007, 194:63-76 (Pubitemid 47162888)
34. Morissette MR, Stricker JC, Rosenberg MA, Buranasombati C, Levitan EB, Mittleman MA, Rosenzweig A: Effects of myostatin deletion in aging mice. Aging Cell 2009, 8:573-583
35. Amthor H, Otto A, Vulin A, Rochat A, Dumonceaux J, Garcia L, Mouisel E, Hourde C, Macharia R, Friedrichs M, Relaix F, Zammit PS, Matsakas A, Patel K, Partridge T: Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activity. Proc Natl Acad Sci U S A 2009, 106:7479-7484
36. McGeachie JK, Grounds MD, Partridge TA, Morgan JE: Age-related changes in replication of myogenic cells in mdx mice: quantitative autoradiographic studies. J Neurol Sci 1993, 119:169-179
37. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL: Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci U S A 1993, 90:3710-3714
38. Karpati G, Carpenter S: Small-caliber skeletal muscle fibers do not suffer deleterious consequences of dystrophic gene expression. Am J Med Genet 1986, 25:653-658 (Pubitemid 17191439)
39. Gehrig SM, Koopman R, Naim T, Tjoakarfa C, Lynch GS: Making fast-twitch dystrophic muscles bigger protects them from contraction injury and attenuates the dystrophic pathology. Am J Pathol 2010, 176:29-33